The efficacy and safety of ganaxolone for the treatment of refractory epilepsy: A meta‐analysis from randomized controlled trials

OBJECTIVE: Epilepsy is one of the most common and refractory neurological disorders globally. Ganaxolone, a neuroactive steroid that enhances GABAergic inhibition, has been tested in many trials for the resolution of refractory epilepsy. Based on these, our study implemented a meta‐analysis to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jiahao, Yan, Zeya, Tao, Xinyu, Wang, Wei, Wang, Fei, Xue, Tao, Liu, Yanfei, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978077/
https://www.ncbi.nlm.nih.gov/pubmed/36333279
http://dx.doi.org/10.1002/epi4.12669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978077/
https://www.ncbi.nlm.nih.gov/pubmed/36333279
http://dx.doi.org/10.1002/epi4.12669

Ejemplares similares